Untitled
BCHM503: Advanced Cellular Biochemistry
Overview
- Date: 3/1/2024
- Instructor: Sue Fitzmaurice
- Topics covered:
- Galactose and Fructose Metabolism
- HMP Shunt / Pentose Phosphate Pathway
- Reference Materials: BMB, Chap 22 (440-443), Chap 27 (545-550)
Galactose Metabolism
Key Components
- Galactose: A monosaccharide part of lactose.
- Enzymes involved:
- Lactase: Breaks down lactose into glucose and galactose.
- Galactokinase: Converts galactose to galactose-1-phosphate (Gal-1-P).
- Galactose 1-Phosphate Uridyl Transferase: Converts Gal-1-P into glucose-1-phosphate (Glc-1-P).
- UDP-Galactose-4-Epipmerase: Converts UDP-galactose to UDP-glucose.
Pathway Summary
- Conversion Process:
- Galactose -> Galactose-1-P via Galactokinase
- Galactose-1-P -> UDP-Galactose via galactose 1-P uridyl transferase
- UDP-Galactose -> UDP-Glucose via epimerase
- UDP-Glucose -> Glycogen or glycolysis for energy production
Clinical Correlation
Lactase deficiency
- Symptoms after lactose ingestion include:
- Diarrhea
- Bloating
- Cramps
- Primary Lactose Intolerance: Hereditary condition, common in Asian and African descent.
- Secondary Lactose Intolerance: Can develop due to gastrointestinal disturbances such as celiac sprue or colitis.
- Diagnosis through positive hydrogen breath test.
- Treatment includes dietary modifications (excluding lactose) or lactase supplements.
Genetic Conditions
Galactokinase Deficiency
- Autosomal recessive trait
- Leads to cataracts in early life due to accumulation of galactitol (from galactose).
- Treatment involves eliminating galactose from the diet.
Galactose-1-Phosphate Uridyltransferase Deficiency (Classic Galactosemia)
- Symptoms include:
- Cataracts
- Vomiting
- Diarrhea after milk ingestion
- Liver damage, hyperbilirubinemia
- Mental impairment over time
- Early diagnosis and management can lead to normal life expectancy through dietary management.
Fructose Metabolism
Overview
- Source of fructose includes fruits, sucrose (table sugar), and honey.
- Fructose metabolism primarily occurs in the liver following absorption.
Metabolic Pathway
- Conversion Process:
- Fructose -> Fructose-1-Phosphate (via Fructokinase)
- Fructose-1-P cleaved by Aldolase B into:
- Dihydroxyacetone Phosphate (DHAP)
- Glyceraldehyde
- Rate of Metabolism: Fructose is metabolized more rapidly than glucose in the liver.
Clinical Correlation
Fructokinase Deficiency
- Condition is benign, leads to Essential Fructosuria.
Aldolase B Deficiency (Hereditary Fructose Intolerance)
- Symptoms include:
- Severe hypoglycemia and lactic acidosis after fructose ingestion
- Vomiting, lethargy, and diarrhea
- Liver damage and jaundice
- Treatment requires dietary restriction of fructose and sucrose.
HMP Shunt/Pentose Phosphate Pathway
Overview
- Pathway operates parallel to glycolysis, providing NADPH and ribose-5-phosphate.
Key Enzymes and Functions
- Key Enzymes:
- Glucose-6-Phosphate Dehydrogenase (G6PDH)
- Transketolase: Transfers two-carbon units.
- Functions:
- Generates NADPH for
- Fatty acid and cholesterol biosynthesis
- Antioxidant defenses (maintenance of glutathione levels)
- Detoxification Reactions: Cytochrome P450 reactions require NADPH.
Clinical Correlation
G6PD Deficiency
- Common X-linked disorder leading to hemolytic anemia when exposed to oxidative stressors (drugs, fava beans).
- Symptoms include hemoglobinuria, jaundice, and anemia.
- Favism: Severe hemolytic reaction after ingestion of fava beans in affected individuals.
- Management involves avoiding known triggers and monitoring for complications.
Functions of NADPH
- Key Roles in the Body:
- Antioxidant defense: Maintains reduced glutathione levels.
- Essential for detoxification of oxidants.
- Required in fatty acid and cholesterol synthesis.
- Sources of NADPH: Notably produced in the liver, contributing to overall metabolic processes.
Conclusion
- Understanding carbohydrate metabolism (galactose, fructose) and the role of the HMP shunt is crucial in biochemistry, particularly in clinical applications related to metabolic disorders.
- Ongoing studies continue to elucidate the complexities of these pathways and their implications for human health and disease management.